183 related articles for article (PubMed ID: 32043806)
1. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
[TBL] [Abstract][Full Text] [Related]
3. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons.
Annamalai T; Cheng B; Keswani N; Tse-Dinh YC
Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
[TBL] [Abstract][Full Text] [Related]
5. A surface plasmon resonance study of the intermolecular interaction between Escherichia coli topoisomerase I and pBAD/Thio supercoiled plasmid DNA.
Tiwari PB; Annamalai T; Cheng B; Narula G; Wang X; Tse-Dinh YC; He J; Darici Y
Biochem Biophys Res Commun; 2014 Mar; 445(2):445-50. PubMed ID: 24530905
[TBL] [Abstract][Full Text] [Related]
6. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
Tse-Dinh YC
Future Med Chem; 2015; 7(4):459-71. PubMed ID: 25875873
[TBL] [Abstract][Full Text] [Related]
7. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I.
Cheng B; Liu IF; Tse-Dinh YC
J Antimicrob Chemother; 2007 Apr; 59(4):640-5. PubMed ID: 17317696
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
Cheng B; Annamalai T; Sandhaus S; Bansod P; Tse-Dinh YC
PLoS One; 2015; 10(3):e0120022. PubMed ID: 25798600
[TBL] [Abstract][Full Text] [Related]
9. Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I.
Yang Z; Jiang T; Zhong H; Kang Y
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):319-323. PubMed ID: 29281935
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison.
Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
Biochem Biophys Res Commun; 2014 Apr; 446(4):916-20. PubMed ID: 24642256
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.
Sandhaus S; Chapagain PP; Tse-Dinh YC
Sci Rep; 2018 Jan; 8(1):1437. PubMed ID: 29362471
[TBL] [Abstract][Full Text] [Related]
12. Characterization of DNA topoisomerase I from Mycobacterium tuberculosis: DNA cleavage and religation properties and inhibition of its activity.
Godbole AA; Leelaram MN; Bhat AG; Jain P; Nagaraja V
Arch Biochem Biophys; 2012 Dec; 528(2):197-203. PubMed ID: 23085346
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
14. Characterization of molecular interactions between Escherichia coli RNA polymerase and topoisomerase I by molecular simulations.
Tiwari PB; Chapagain PP; Banda S; Darici Y; Üren A; Tse-Dinh YC
FEBS Lett; 2016 Sep; 590(17):2844-51. PubMed ID: 27448274
[TBL] [Abstract][Full Text] [Related]
15. 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.
Bansal S; Sinha D; Singh M; Cheng B; Tse-Dinh YC; Tandon V
J Antimicrob Chemother; 2012 Dec; 67(12):2882-91. PubMed ID: 22945915
[TBL] [Abstract][Full Text] [Related]
16. Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex.
Sutherland JH; Tse-Dinh YC
J Bacteriol; 2010 Sep; 192(17):4445-51. PubMed ID: 20601468
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
Sandhaus S; Annamalai T; Welmaker G; Houghten RA; Paz C; Garcia PK; Andres A; Narula G; Rodrigues Felix C; Geden S; Netherton M; Gupta R; Rohde KH; Giulianotti MA; Tse-Dinh YC
Antimicrob Agents Chemother; 2016 Jul; 60(7):4028-36. PubMed ID: 27114277
[TBL] [Abstract][Full Text] [Related]
19. Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.
Ranjan N; Story S; Fulcrand G; Leng F; Ahmad M; King A; Sur S; Wang W; Tse-Dinh YC; Arya DP
J Med Chem; 2017 Jun; 60(12):4904-4922. PubMed ID: 28513176
[TBL] [Abstract][Full Text] [Related]
20. Bacterial cell killing mediated by topoisomerase I DNA cleavage activity.
Cheng B; Shukla S; Vasunilashorn S; Mukhopadhyay S; Tse-Dinh YC
J Biol Chem; 2005 Nov; 280(46):38489-95. PubMed ID: 16159875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
